Research on China Diagnostic Reagent Industry, 2015

Publisher Name :
Date: 27-May-2015
No. of pages: 160

After 30 years of development, the China's diagnostic reagent industry achieved a market size of nearly RMB 20 billion in 2014, a YoY growth of 15.7%. Currently nearly 90% downstream users of China's diagnostic reagent market comes from hospitals.

There's still a huge growth potential in China's diagnostic reagent industry. China accounts for 20% of total population worldwide, but only take up 7% of global diagnostic reagent market in 2014. The average diagnostic reagent expense in China is only around $3, far below the average of $28 in the developed countries.

Currently there are about 300 diagnostic reagent enterprises in China and the industry concentration is still low. Large companies in China include: KHB, Da An Gene, Maker, HTA etc. Foreign brands accounts for over 50% of China's diagnostic reagent market in 2014, especially in high-end fields. The market share of domestic enterprises mainly comes from biochemical reagents.

China has fulfilled the import substitution of biochemical reagents, intensified competition has largely squeezed the profits in this subfield. Chemiluminescence Immunoassay (CLIA) and molecular diagnosis will be the most promising subfields in China's diagnostic reagent industry.

New Industries Biomedical Engineering Co., Ltd is the leading CLIA enterprise in China. Currently the company owns 102 chemiluminescent reagents and 8 models of CLIA analyzer. The company achieved reagents sales of RMB 331 million and reagents products has exported to Swiss, France, and Italy etc.

Zeesan Biotech is the leading molecular diagnosis enterprise in China. The company achieved molecular diagnosis reagents sales of RMB 11.85 million in 2014. Zeesan's products covers infectious disease (mainly phthisis), tumor (mainly leukemia) and genetic disease.

Research on China Diagnostic Reagent Industry, 2015

Table of Contents

1 Overview
1.1 Classification
1.2 Policy
1.3 Industry Chain

2 Market Landscape
2.1 Overview
2.2 Market Segement
2.2.1 Immunodiagnosis
2.2.2 Molecular Diagnosis
2.2.3 Biochemical Diagnosis
2.3 Competition
2.4 Import & Export
2.4.1 Import
2.4.2 Export

3 Major Enterprises
3.1 Shanghai Kehua Bio-engineering Co., Ltd. (KHB)
3.1.1 Company Profile
3.1.2 Key Financial Data
3.1.3 Competitiveness Analysis
3.1.7 Diagnostic Reagent Business
3.2 Beijing Strong Biotechnologies, Inc (BSBE)
3.2.1 Profile
3.2.2 Key Financial Data
3.2.3 Competitiveness Analysis
3.2.4 Diagnostic Reagent Business
3.3 Da An Gene
3.3.1 Company Profile
3.3.2 Key Financial Data
3.3.3 Competitiveness Analysis
3.3.4 Diagnostic Reagent Business
3.4 Fosun Pharmaceutical
3.4.1 Company Profile
3.4.2 Key Financial Data
3.4.3 Competitiveness Analysis
3.4.4 Diagnostic Reagent Business
3.5 Beijing Leadman Biochemistry Co., Ltd.
3.5.1 Company Profile
3.5.2 Key Financial Data
3.5.3 Competitiveness Analysis
3.5.4 Diagnostic Reagent Business
3.6 Livzon Pharmaceutical Group Inc.
3.6.1 Company Profile
3.6.2 Key Financial Data
3.6.3 Competitiveness Analysis
3.6.4 Diagnostic Reagent Business
3.7 Mindray Medical
3.7.1 Company Profile
3.7.2 Key Financial Data
3.7.3 Competitiveness Analysis
3.7.4 Diagnostic Reagent Business
3.8 Biosino Bio-Technology & Science Inc.
3.8.1 Company Profile
3.8.2 Key Financial Data
3.8.3 Competitiveness Analysis
3.8.4 Diagnostic Reagent Business
3.9 Maker Biotechnology
3.9.1 Company Profile
3.9.2 Key Financial Data
3.9.3 Competitiveness Analysis
3.9.4 Diagnostic Reagent Business
3.10 Sinocare
3.10.1 Company Profile
3.10.2 Key Financial Data
3.10.3 Competitiveness Analysis
3.10.4 Diagnostic Reagent Business
3.11 Beijing Kinghawk Pharmaceutical Co., Ltd.
3.11.1 Company Profile
3.11.2 Key Financial Data
3.11.3 Competitiveness Analysis
3.11.4 Diagnostic Reagent Business
3.12 Bohui Innovation
3.12.1 Company Profile
3.12.2 Key Financial Data
3.12.3 Competitiveness Analysis
3.12.4 Diagnostic Reagent Business
3.13 Health BioMed
3.13.1 Company Profile
3.13.2 Key Financial Data
3.13.3 Competitiveness Analysis
3.13.4 Diagnostic Reagent Business
3.14 Wondfo
3.14.1 Company Profile
3.14.2 Key Financial Data
3.14.3 Competitiveness Analysis
3.14.4 Diagnostic Reagent Business
3.15 Thalys
3.15.1 Company Profile
3.15.2 Key Financial Data
3.15.3 Competitiveness Analysis
3.15.4 Diagnostic Reagent Business
3.16 SHINVA
3.16.1 Company Profile
3.16.2 Key Financial Data
3.16.3 Competitiveness Analysis
3.16.4 Diagnostic Reagent Business
3.17 Humanwell Healthcare
3.17.1 Company Profile
3.17.2 Key Financial Data
3.17.3 Diagnostic Reagent Business
3.18 HTA CO. LTD
3.18.1 Company Profile
3.18.2 Key Financial Data
3.18.3 Diagnostic Reagent Business
3.19 New Indutries Biomedical Engineering
3.19.1 Company Profile
3.19.2 Key Financial Data
3.19.3 Diagnostic Reagent Business
3.20 Sichuan Xincheng Biological
3.20.1 Company Profile
3.20.2 Key Financial Data
3.20.3 Diagnostic Reagent Business
3.21 MultiSciences Biotech
3.21.1 Company Profile
3.21.2 Key Financial Data
3.21.3 Diagnostic Reagent Business
3.22 Surexam
3.22.1 Company Profile
3.22.2 Key Financial Data
3.22.3 Diagnostic Reagent Business
3.23 Shanghai Kexin Biotech
3.23.1 Company Profile
3.23.2 Key Financial Data
3.23.3 Diagnostic Reagent Business
3.24 Shanghai Fenghui Medical Science and Technology
3.24.1 Company Profile
3.24.2 Key Financial Data
3.24.3 Diagnostic Reagent Business
3.25 Beijing The Place Bio-Tech
3.25.1 Company Profile
3.25.2 Key Financial Data
3.25.3 Diagnostic Reagent Business
3.26 Beijing The Place Bio-Tech
3.26.1 Company Profile
3.26.2 Key Financial Data
3.26.3 Diagnostic Reagent Business
3.27 Shanghai GenePharma
3.27.1 Company Profile
3.27.2 Key Financial Data
3.27.3 Diagnostic Reagent Business
3.28 Suzhou GenePharma
3.28.1 Company Profile
3.28.2 Key Financial Data
3.28.3 Diagnostic Reagent Business
3.29 EasyDiagnosis Biomedicine
3.29.1 Company Profile
3.29.2 Key Financial Data
3.29.3 Diagnostic Reagent Business
3.30 King Diagnostic Technology
3.30.1 Company Profile
3.30.2 Key Financial Data
3.30.3 Diagnostic Reagent Business
3.31 Zeesan Biotech
3.31.1 Company Profile
3.31.2 Key Financial Data
3.31.3 Diagnostic Reagent Business
3.32 Baibo Biotechnology
3.32.1 Company Profile
3.32.2 Key Financial Data
3.32.3 Diagnostic Reagent Business
3.33 Nymphavn Biotechnology
3.33.1 Company Profile
3.33.2 Key Financial Data
3.33.3 Diagnostic Reagent Business
3.34 Shuguang HZK Biological Technology
3.34.1 Company Profile
3.34.2 Key Financial Data
3.34.3 Diagnostic Reagent Business
3.35 Medicalsystem Biotechnology
3.35.1 Company Profile
3.35.2 Key Financial Data
3.35.3 Diagnostic Reagent Business

4 Industry Main Indicator

List of Charts

Classification of In Vitro Diagnostic Reagents (by Detection Principle)
2005-2013 Main Policies of China Diagnostic Reagent Industry
Industry Chain of Diagnostic Reagent
2009-2014 Market Size of In Vitro Diagnostics in China
2014 Market Structure of China’s In Vitro Diagnostic Reagent
2010-2015 Market Size of China’s Immunodiagnosis Market by Products
Domestic Enterprises with Chemiluminescence Immunoassay (CLIA) Products
Numbers of DLIA Diagnostic Reagents by Domestic Enterprises
2007-2013 Numbers of Molecular Diagnosis Project in China
2010-2015 Market Size of Biochemical Diagnosis in China
Diagnostic Instrument Comparison between Domestic and Foreign Enterprises
Competition Pattern of China’s Diagnostic Reagent Industry
Development Strategies of Leading Diagnostic Reagent Companies Worldwide
2009-2013 Gross Margin Comparison between Major Diagnostic Reagent Companies in China
2009-2014 Revenue Comparison between Major In Vitro Diagnostics Companies in China
2008-2014 Import Volume of China’s Diagnostic Reagent
2008-2014 Import Value of China’s Diagnostic Reagent
2012-2014 Import Sources and Value of China’s Diagnostic Reagent
2008-2014 Export Volume of China’s Diagnostic Reagent
2008-2014 Export Value of China’s Diagnostic Reagent
2012-2014 Export Volume and Value of Chinese Diagnostic Reagents by Countries
2009-2014 Revenue and Net Income of KHB
2009-2014 Revenue Structure of KHB by Product
2009-2014 Gross Margin of KHB by Product

  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs